Group leader
Alberto Villanueva
Principal investigators
Enric Condom
David Garcia
Ernest Nadal
PhD students
Nerea Albert
Samuel Gonçalves
Technicians
Griselda Venturas
Maria Martinez
Monica Calaf
Natalia Guillen
Sara Puertas
Scientific production
22
PAPERS
203,484
TOTAL IF
9,690
MEAN IF
17 PUBLICATIONS IN FIRST QUARTILE
10 PUBLICATIONS IN FIRST DECILE
Highlights
- Esteller M; Guil S; Diederichs S; Gross M; Villanueva A; Farré L; Martinez-Iniesta M; Akiyama Y; Sala N; Galan M; Paúles M; Vidal A; Espada J; Moutinho C; Heyn H; Gómez A; Martínez-Cardús A; Hashimoto Y; Sandoval J; Goyal A; Setien F; Soler M; Lopez-Serra P; Crujeiras A; Diaz-Lagares A. Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer. Proceedings Of The National Academy Of Sciences Of The United States Of America 2016. DOI: 10.1073/pnas.1608585113
- Diaz-Lagares, A; Mendez-Gonzalez, J; Hervas, D; Saigi, M; Pajares, MJ; Garcia, D; Crujeiras, AB; Pio, R; Montuenga, LM; Zulueta, J; Nadal, E; Rosell, A; Esteller, M; Sandoval Del Amor, J. A novel epigenetic signature for early diagnosis in lung cancer. Clinical Cancer Research 2016. DOI: 10.1158/1078-0432.CCR-15-2346
- XENOPAT spin-off